OxyContin Reformulation Reduced Abuse Via Non-Oral Routes But Not Overall Abuse, US FDA Finds

 
• By Brenda Sandburg
Oxycontin
FDA finds reformulated OxyContin reduces abuse of the product via non-oral routes

More from US FDA Performance Tracker

More from Regulatory Trackers